在酒精性隔膜切除和隔膜肌切除后的死亡率,在患有阻塞性高性心肌病的患者中
Risako Yasuda1, Itsuki Osawa2, Tadahiro Goto3
1Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center New York, NY USA.
Circulation reports
|March 11, 2024
概括
酒精隔膜切除 (ASA) 与隔膜肌切除 (SM) 相比,与阻塞性多变性心肌病 (HCM) 患者的1年死亡率较低有关. 这项现实研究发现ASA是隔膜缩小疗法的更安全选择.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 阻塞性缩性心肌病 (HCM) 通常需要隔膜缩小疗法 (SRT).
- 酒精隔膜切除 (ASA) 和隔膜肌切除 (SM) 是主要的SRT选择.
- 在ASA和SM之后的比较死亡率的现实数据有限.
研究的目的:
- 为了在HCM患者中比较ASA和SM之间的1年全因死亡率.
- 在基于人口的环境中评估不同SRT方法的有效性.
主要方法:
- 一项使用纽约SPARCS数据库 (2005-2016) 的比较有效性研究.
- 包括755名患有HCM的患者,他们接受了ASA (n=348) 或SM (n=407).
- 统计分析包括多变量后勤回归,倾向性得分匹配和IPTW.
主要成果:
- 酒精隔膜切除 (ASA) 与手术后360天所有原因的死亡人数显著减少 (aOR=0.34,P=0.02).
- 倾向性得分匹配和IPTW分析证实了ASA的较低死亡风险.
- 该研究发现,与SM相比,ASA的1年死亡率较低.
结论:
- 在现实世界中,酒精隔膜切除 (ASA) 显示,与隔膜切除 (SM) 相比,阻塞性缩性心肌病的1年全因死亡率明显较低.
- 对于符合条件的HCM患者来说,ASA可能是一个更安全的隔膜缩小疗法选择.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


